Zydus Lifesciences receives tentative FDA approval for Letermovir tablets

Zydus Lifesciences receives tentative FDA approval for Letermovir tablets

In a significant development for patients undergoing bone marrow or kidney transplants, Zydus Lifesciences Limited has been granted tentative approval by the United States Food and Drug Administration (USFDA) for its Letermovir tablets in 240 mg and 480 mg formulations. This approval marks a crucial step in preventing disease caused by cytomegalovirus (CMV) in these […]

WebMD snaps up operating assets of health education firm Healthwise

WebMD snaps up operating assets of health education firm Healthwise

In a significant development within the healthcare information services sector, WebMD Health Corp., a subsidiary of Internet Brands and a frontrunner in providing health information services to consumers, physicians, and other healthcare professionals, announced its acquisition of the operating assets of Healthwise, Incorporated. This move is poised to enhance WebMD’s offerings and extend its reach […]

Breakthrough Alzheimer’s treatments on the horizon: New drugs and potential vaccine

Breakthrough Alzheimer’s treatments on the horizon: New drugs and potential vaccine

Global Health Update — Promising developments in the fight against Alzheimer’s disease could significantly alter the landscape of treatment and prevention within the next decade. Experts are optimistic about the introduction of an effective drug to treat Alzheimer’s soon, with a potential vaccine to prevent the disease possibly available within ten years. Advances in Alzheimer’s […]